{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T17:12:25Z","timestamp":1762881145290,"version":"3.45.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["DARU J Pharm Sci"],"DOI":"10.1007\/s40199-025-00574-x","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T06:18:10Z","timestamp":1761286690000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of clinical and safety outcomes of generic tacrolimus (Suprotac\u00a0$$\\circledR$$) versus branded tacrolimus (Prograf\u00a0$$\\circledR$$) in de novo liver transplant patients: a randomized clinical trial"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8661-1838","authenticated-orcid":false,"given":"Mojtaba","family":"Shafiekhani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Amin","family":"Jafarzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6174-8907","authenticated-orcid":false,"given":"Mohammad","family":"Ahmadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0708-334X","authenticated-orcid":false,"given":"Hamed","family":"Nikoupour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3798-6064","authenticated-orcid":false,"given":"Alireza","family":"Shamsaeefar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keynoosh","family":"Jafari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sahar","family":"Sohrabi Nazari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kianaz","family":"Kafilzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siavash","family":"Gholami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edalat","family":"Zarei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kourosh","family":"Kazemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Araz","family":"Sabzvari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0853-9938","authenticated-orcid":false,"given":"Seyed Ali Malek","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4530-8829","authenticated-orcid":false,"given":"Saman","family":"Nikeghbalian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,24]]},"reference":[{"issue":"4","key":"574_CR1","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.surg.2018.04.039","volume":"164","author":"F Baganate","year":"2018","unstructured":"Baganate F, Beal EW, Tumin D, Azoulay D, Mumtaz K, Black SM, et al. Early mortality after liver transplantation: defining the course and the cause. Surgery. 2018;164(4):694\u2013704.","journal-title":"Surgery"},{"issue":"2","key":"574_CR2","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/aor.13551","volume":"44","author":"Y Bentata","year":"2020","unstructured":"Bentata Y. Tacrolimus: 20 years of use in adult kidney transplantation. what we should know about its nephrotoxicity. Artif Org. 2020;44(2):140\u201352.","journal-title":"Artif Org"},{"issue":"12","key":"574_CR3","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1111\/ctr.12455","volume":"28","author":"E Dannhorn","year":"2014","unstructured":"Dannhorn E, Cheung M, Rodrigues S, Cooper H, Thorburn D, Patch D, et al. De novo use of generic tacrolimus in liver transplantation\u2013a single center experience with one-yr follow-up. Clin Transplant. 2014;28(12):1349\u201357.","journal-title":"Clin. Transplant."},{"key":"574_CR4","doi-asserted-by":"crossref","unstructured":"Gantar K, \u0160kerget K, Mochkin I, Bajc A. Meeting regulatory requirements for drugs with a narrow therapeutic index: bioequivalence studies of generic once-daily tacrolimus. Drug, Healthcare and Patient Safety. 2020. p. 151\u201360.","DOI":"10.2147\/DHPS.S256455"},{"issue":"17","key":"574_CR5","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.2146\/ajhp120783","volume":"70","author":"MS Heavner","year":"2013","unstructured":"Heavner MS, Tichy EM, Yazdi M, Formica RN Jr, Kulkarni S, Emre S. Clinical outcomes associated with conversion from brand-name to generic tacrolimus in hospitalized kidney transplant recipients. Am J Health Syst Pharm. 2013;70(17):1507\u201312.","journal-title":"Am. J. Health Syst. Pharm."},{"issue":"9","key":"574_CR6","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1001\/jama.2020.1012","volume":"323","author":"I Hernandez","year":"2020","unstructured":"Hernandez I, San-Juan-Rodriguez A, Good CB, Gellad WF. Changes in list prices, net prices, and discounts for branded drugs in the us, 2007-2018. JAMA. 2020;323(9):854\u201362.","journal-title":"JAMA"},{"issue":"7","key":"574_CR7","first-page":"275","volume":"21","author":"SA Malek-Hosseini","year":"2018","unstructured":"Malek-Hosseini SA, Jafarian A, Nikeghbalian S, Poustchi H, Lankarani KB, Toosi MN, et al. Liver transplantation status in iran: a multi-center report on the main transplant indicators and survival rates. Arch Iran Med. 2018;21(7):275\u201382.","journal-title":"Arch. Iran. Med."},{"issue":"6","key":"574_CR8","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1097\/TP.0b013e31822a79ad","volume":"92","author":"LM McDevitt-Potter","year":"2011","unstructured":"McDevitt-Potter LM, Sadaka B, Tichy EM, Rogers CC, Gabardi S. A multicenter experience with generic tacrolimus conversion. Transplantation. 2011;92(6):653\u20137.","journal-title":"Transplantation"},{"key":"574_CR9","doi-asserted-by":"publisher","first-page":"101355","DOI":"10.1016\/j.trim.2020.101355","volume":"64","author":"IZ Miotto","year":"2021","unstructured":"Miotto IZ, de\u00a0Castro e\u00a0Souza B, Tyring SK, Roncalli\u00a0Pereira de\u00a0Oliveira W. Immunosuppressant-induced cutaneous drug reactions in solid organ transplant recipients. Transpl Immunol. 2021;64:101355.","journal-title":"Transpl. Immunol."},{"issue":"9","key":"574_CR10","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1111\/j.1600-6143.2011.03615.x","volume":"11","author":"JD Momper","year":"2011","unstructured":"Momper JD, Ridenour TA, Schonder KS, Shapiro R, Humar A, Venkataramanan R. The impact of conversion from prograf to generic tacrolimus in liver and kidney transplant recipients with stable graft function. Am J Transplant. 2011;11(9):1861\u20137.","journal-title":"Am. J. Transplant."},{"issue":"3","key":"574_CR11","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1097\/TP.0000000000003350","volume":"105","author":"SC Ong","year":"2021","unstructured":"Ong SC, Gaston RS. Thirty years of tacrolimus in clinical practice. Transplantation. 2021;105(3):484\u201395.","journal-title":"Transplantation"},{"key":"574_CR12","doi-asserted-by":"publisher","first-page":"10263","DOI":"10.3389\/ti.2022.10263","volume":"35","author":"MT Serrano","year":"2022","unstructured":"Serrano MT, Sabroso S, Esteban LM, Berenguer M, Fondevila C, Lorente S, et al. Mortality and causes of death after liver transplantation: analysis of sex differences in a large nationwide cohort. Transpl Int. 2022;35:10263.","journal-title":"Transpl. Int."},{"issue":"11","key":"574_CR13","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1002\/phar.1130","volume":"32","author":"MM Spence","year":"2012","unstructured":"Spence MM, Nguyen LM, Hui RL, Chan J. Evaluation of clinical and safety outcomes associated with conversion from brand-name to generic tacrolimus in transplant recipients enrolled in an integrated health care system. Pharmacotherapy: J Human Pharmacol Drug Therapy. 2012;32(11):981\u20137.","journal-title":"Pharmacotherapy: J Human Pharmacol Drug Therapy"},{"issue":"3","key":"574_CR14","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.japh.2023.02.006","volume":"63","author":"KA Tanni","year":"2023","unstructured":"Tanni KA, Qian J. Comparative safety of generic versus brand calcineurin inhibitors in solid organ transplant patients: a systematic review and meta-analysis. J Am Pharm Assoc. 2023;63(3):709\u201319.","journal-title":"J. Am. Pharm. Assoc."},{"issue":"5","key":"574_CR15","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/ctr.12336","volume":"28","author":"D Taube","year":"2014","unstructured":"Taube D, Jones G, O\u2019Beirne J, Wennberg L, Connor A, Rasmussen A, et al. Generic tacrolimus in solid organ transplantation. Clin Transplant. 2014;28(5):623\u201332.","journal-title":"Clin. Transplant."},{"issue":"11","key":"574_CR16","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1097\/01.tp.0000181195.67084.94","volume":"80","author":"L Tricot","year":"2005","unstructured":"Tricot L, Lebb\u00e9 C, Pillebout E, Martinez F, Legendre C, Thervet E. Tacrolimus-induced alopecia in female kidney-pancreas transplant recipients. Transplantation. 2005;80(11):1546\u20139.","journal-title":"Transplantation"},{"issue":"1","key":"574_CR17","doi-asserted-by":"publisher","first-page":"67","DOI":"10.5152\/tjg.2024.24051","volume":"36","author":"O Y\u00fcksekyayla","year":"2025","unstructured":"Y\u00fcksekyayla O, Bat\u0131bay E, Wahlin S, Efe C. Alopecia in patients with autoimmune hepatitis treated by tacrolimus therapy. Turk J Gastroenterol. 2025;36(1):67.","journal-title":"Turk. J. Gastroenterol."},{"issue":"1","key":"574_CR18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S1499-3872(16)60167-4","volume":"16","author":"W Zhang","year":"2017","unstructured":"Zhang W, Fung J. Limitations of current liver transplant immunosuppressive regimens: renal considerations. Hepatobiliary & Pancreatic Diseases Int. 2017;16(1):27\u201332.","journal-title":"Hepatobiliary & Pancreatic Diseases Int"}],"container-title":["DARU Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40199-025-00574-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40199-025-00574-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40199-025-00574-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T17:08:20Z","timestamp":1762880900000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40199-025-00574-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":18,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["574"],"URL":"https:\/\/doi.org\/10.1007\/s40199-025-00574-x","relation":{},"ISSN":["2008-2231"],"issn-type":[{"type":"electronic","value":"2008-2231"}],"subject":[],"published":{"date-parts":[[2025,10,24]]},"assertion":[{"value":"17 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was provided from all patients prior to participation, with the option to withdraw at any point during the study. Ethical approval was granted by the Shiraz University of Medical Sciences Regional Ethics Board (IR.SUMS.REC.1400.308).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The trial was registered in the Iranian Registry of Clinical Trials under the identifier IRCT20150303021315N25.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare no conflict of interest other than financial support of the study by CinnaGen\u00ae Company. CinnaGen\u00ae Company financially supported this study. The sponsor had no role in the study design or the collection, analysis, asnd interpretation of data, writing of the report, or decision to submit the article for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest and funding support"}}],"article-number":"35"}}